Neuroprotection for traumatic brain injury: translational challenges and emerging therapeutic strategies
about
Gene expression patterns following unilateral traumatic brain injury reveals a local pro-inflammatory and remote anti-inflammatory responseNedd4 family interacting protein 1 (Ndfip1) is required for ubiquitination and nuclear trafficking of BRCA1-associated ATM activator 1 (BRAT1) during the DNA damage responseThe Role of Cyclo(His-Pro) in NeurodegenerationTraumatic brain injury: pathophysiology for neurocritical careEfficacy of progesterone for moderate to severe traumatic brain injury: a meta-analysis of randomized clinical trialsSystems biology approaches for discovering biomarkers for traumatic brain injuryNeuroprotection for traumatic brain injuryStudies of selective TNF inhibitors in the treatment of brain injury from stroke and trauma: a review of the evidence to dateNeuroprotective strategies for traumatic brain injury: improving clinical translationAnimal models of traumatic brain injuryUsing Drosophila as an integrated model to study mild repetitive traumatic brain injury.Utilizing pharmacotherapy and mesenchymal stem cell therapy to reduce inflammation following traumatic brain injuryEmerging therapies in traumatic brain injuryHsp70 inducer, 17-allylamino-demethoxygeldanamycin, provides neuroprotection via anti-inflammatory effects in a rat model of traumatic brain injurySelective inhibition of matrix metalloproteinase-9 attenuates secondary damage resulting from severe traumatic brain injurySubacute intranasal administration of tissue plasminogen activator promotes neuroplasticity and improves functional recovery following traumatic brain injury in ratsStructured evaluation of rodent behavioral tests used in drug discovery research.CR8, a selective and potent CDK inhibitor, provides neuroprotection in experimental traumatic brain injury.Caffeic Acid phenethyl ester protects blood-brain barrier integrity and reduces contusion volume in rodent models of traumatic brain injury.Candesartan, an angiotensin II AT₁-receptor blocker and PPAR-γ agonist, reduces lesion volume and improves motor and memory function after traumatic brain injury in mice.Prostaglandin F2α FP receptor antagonist improves outcomes after experimental traumatic brain injuryNeuroimaging after mild traumatic brain injury: review and meta-analysis.Angiotensin receptor type 2 activation induces neuroprotection and neurogenesis after traumatic brain injury.Comparison of neurite density measured by MRI and histology after TBI.Postsynaptic scaffold protein Homer 1a protects against traumatic brain injury via regulating group I metabotropic glutamate receptors.Can structural or functional changes following traumatic brain injury in the rat predict epileptic outcome?Therapeutic Prospective of Infused Allogenic Cultured Mesenchymal Stem Cells in Traumatic Brain Injury Mice: A Longitudinal Proton Magnetic Resonance Spectroscopy AssessmentA new avenue for lithium: intervention in traumatic brain injury.The Effects of Chunghyul-Dan, an Agent of Korean Medicine, on a Mouse Model of Traumatic Brain InjuryThe Role of Substance P in Secondary Pathophysiology after Traumatic Brain Injury.Microglial Activation in Traumatic Brain Injury.bFGF Protects Against Blood-Brain Barrier Damage Through Junction Protein Regulation via PI3K-Akt-Rac1 Pathway Following Traumatic Brain InjuryBone marrow mesenchymal stromal cells drive protective M2 microglia polarization after brain traumaLow-level laser therapy effectively prevents secondary brain injury induced by immediate early responsive gene X-1 deficiency.Therapeutic effects of pharmacologically induced hypothermia against traumatic brain injury in mice.Is progesterone a worthy candidate as a novel therapy for traumatic brain injury?Development of a database for translational spinal cord injury researchTranscranial low-level laser therapy enhances learning, memory, and neuroprogenitor cells after traumatic brain injury in mice.Expression of miRNAs and their cooperative regulation of the pathophysiology in traumatic brain injurySelective CDK inhibitors: promising candidates for future clinical traumatic brain injury trials.
P2860
Q21266677-4CED7480-94B0-485F-A9EF-30EE4D811A4DQ24316324-F43701C5-E53B-422E-9FDD-8A32D91D02E5Q26741190-CB567979-5C4C-4166-B3CB-A25F6B127CB3Q26749223-61207BE0-B226-40AF-B691-567D9DD1EAFFQ26797813-BBC8286E-5B7D-414B-8A46-6B380B0E5C41Q26824124-15AC343C-F1BF-43B5-9E9E-C2222A86CAE1Q26824808-A5B3F353-0551-4A70-9474-BB61AADB8E12Q27001147-26BE86E9-9286-4598-A252-3616C83E5C66Q27004018-D0319BE2-A5EF-4ADB-ACA4-B6C257448B76Q27025091-4EF12122-00C8-4C9A-BEFA-6F6637D489C6Q27318061-4284D85D-00A8-4BC3-8456-864CD0E91399Q28072473-EED33D93-178B-4065-8D13-34C1A16DBAF9Q28087789-C6CF9E20-8BD2-449F-8E25-B4CC995020F1Q28468618-82918BCF-7033-49C5-A18F-132B2B33B638Q28534597-B4E61A32-DFAE-4C6D-8602-0A3F77700A6AQ28542725-DE9DE9F0-6597-4714-B6E4-72BA77DE123DQ30433294-D245BFFA-3F3B-439C-96FA-92BCC325B5ABQ30513085-A2E590EF-D4FC-4DE1-95D2-E5F1FB299E56Q30513157-8AAAA2C5-7E7E-4ECC-9197-A2355C9ED4DDQ30528431-D14450E4-A24F-4636-9D7B-8F17E6DD2AA7Q30570103-EC803881-B2EE-4CAA-B537-76D8804AB7F5Q30584604-524D1E06-FC0D-4C91-97F5-F3F0E6221A3FQ30585823-0EC79BB2-5A50-41B0-A9FB-5B7340C180FAQ30635381-C042B857-FA56-4D6D-A734-CFCCF360A810Q33654169-3867588E-5C87-4CCB-9F05-D8ACCA6BC624Q33655350-BCCE0BA7-841B-422C-B5B3-698CF2A7CEF1Q33722258-48F31D31-5245-458A-A0C8-C0D118A0E637Q33777980-F4D69914-E381-4369-918C-6B0DB4F22162Q33823964-A28C3F46-370C-4E9C-974B-DE2EA5FBB49DQ33843032-6DBB59F5-51AB-4F5D-818B-5E90553DD09FQ33843373-4C8FF602-4557-47E9-8D03-2B6D727A8254Q33917585-FADFEBD2-61BD-4C2C-AB5A-2D67A5D8B348Q34000812-8B5299A1-1B05-4DAA-86B2-4C7F39D024DBQ34018709-EFDFAD8C-12C6-43A5-8232-C59A8C33F9A0Q34043830-9102C4B6-42FC-4E19-9570-8B1CCE67C596Q34228092-DD704943-0EA0-427C-AF8C-E271D7472B50Q34291263-2501A2CB-11F2-4345-92B8-5C41B4B8E433Q34303465-DAEB77E8-7EB3-427D-9C6F-B79A9C6234D0Q34326053-788E36D0-116E-4CC3-9C52-D79DE0C35BC3Q34412771-F6422481-04DF-4AD7-B07C-65A8E8CEA11C
P2860
Neuroprotection for traumatic brain injury: translational challenges and emerging therapeutic strategies
description
2010 nî lūn-bûn
@nan
2010 թուականի Հոկտեմբերին հրատարակուած գիտական յօդուած
@hyw
2010 թվականի հոտեմբերին հրատարակված գիտական հոդված
@hy
2010年の論文
@ja
2010年論文
@yue
2010年論文
@zh-hant
2010年論文
@zh-hk
2010年論文
@zh-mo
2010年論文
@zh-tw
2010年论文
@wuu
name
Neuroprotection for traumatic ...... merging therapeutic strategies
@ast
Neuroprotection for traumatic ...... merging therapeutic strategies
@en
Neuroprotection for traumatic ...... merging therapeutic strategies
@nl
type
label
Neuroprotection for traumatic ...... merging therapeutic strategies
@ast
Neuroprotection for traumatic ...... merging therapeutic strategies
@en
Neuroprotection for traumatic ...... merging therapeutic strategies
@nl
prefLabel
Neuroprotection for traumatic ...... merging therapeutic strategies
@ast
Neuroprotection for traumatic ...... merging therapeutic strategies
@en
Neuroprotection for traumatic ...... merging therapeutic strategies
@nl
P2860
P1476
Neuroprotection for traumatic ...... merging therapeutic strategies
@en
P2093
Alan I Faden
David J Loane
P2860
P304
P356
10.1016/J.TIPS.2010.09.005
P577
2010-10-29T00:00:00Z